August 22, 2014/Cancer/News & Insight

Florida Cancer Center to Open in 2015

Topping out ceremony notes progress on new Center

CCFLaCancerblg_690x380

On June 5, Cleveland Clinic Florida celebrated the “topping out” of the Egil and Pauline Braathen Center, which will expand cancer care offerings in response to the continual rise in the number of newly diagnosed cancer cases and the need for quality, comprehensive cancer care in South Florida. Last year alone, there were more than 12,000 cancer cases in South Florida.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Funded by a $30 million gift from long-time patient Pauline Braathen, the 144,000-square foot facility, due to open in February 2015, will house Cleveland Clinic Florida’s Cancer Center and the expanded Pauline Braathen Neurological Center. The Cancer Center’s new home in the Egil and Pauline Braathen Center will incorporate new technology and full-spectrum patient services.

“The advanced technology, patient-focused amenities and stellar team in place at the Egil and Pauline Braathen Center will allow us to elevate the quality of cancer care in South Florida and greatly enhance the overall patient experience,” says Steven Roshon, MD, Cleveland Clinic Florida Cancer Center Director.

Treatment Enhancements

A Chemotherapy Infusion Suite is designed to accommodate entire families. Diagnostic and radiation treatment providing advanced and stereotactic radiotherapy using new technology with sub millimeter accuracy and real-time tumor tracking will be one of the first available in the world. Other radiation technology will include Image Guided Radiotherapy, a dedicated CT simulator, 4 Dimension treatment planning and high dose rate radiotherapy, and Varian’s Edge™ radiosurgery system.

Advertisement

Patient Guidance

Genetic counseling will be available to complement the cancer risk assessment and genetic testing process. A range of support programs will help patients navigate the changes and challenges associated with cancer, and patients will be guided by oncology social workers and nurses. A patient resource and education center will provide patients access to written and electronic resource materials and include areas to meet with fellow survivors and medical specialists. The center will serve as a resource for broader community efforts in prevention, early detection, education, outreach and support.

Holistic Care

The new cancer center will offer palliative care, with a focus on relieving pain and other symptoms and meeting patients’ emotional, spiritual and practical needs. Complementary medicine offerings will include massotherapy, reiki, nutrition education, art therapy and a wig boutique.

Cleveland Connection

Along with the enhanced technology and expanded families come additional opportunities for collaboration with Cleveland-based colleagues, including clinical trial access and knowledge exchange.

Advertisement

Related Articles

adverse events from immune checkpoint inhibitors
December 21, 2023/Cancer/News & Insight
Managing Hormone Dysfunction-Related Adverse Events of Immunotherapy for Breast Cancer Treatment

Timing and type of side effects differ greatly from chemotherapy

23-CNR-4274330-CQD-Hero-650×450
October 18, 2023/Cancer/News & Insight
Cleveland Clinic Lerner Research Institute to Host Head & Neck Cancer CME Symposium

Sessions explore treatment advances and multidisciplinary care

23-CNR-4210971-CQD-Hero-650×450 Dr Yu
October 9, 2023/Cancer/News & Insight
Pathway Cross-Talk Suggests New Approach to Glioblastoma Treatment

New research from Cleveland Clinic helps explain why these tumors are so refractory to treatment, and suggests new therapeutic avenues

23-CNR-4071967-CQD-Hero-650×450 scan for triple-negative breast cancer case study
September 19, 2023/Cancer/News & Insight
Patient With Stage 4 Triple-Negative Breast Cancer in Remission 10 Years After Initial Diagnosis

Combination of olaparib and carboplatin results in complete durable response for a patient with BRCA2 and “BRCAness” mutations

23-CNR-4140381-CQD-Hero-650×450 eye toxicities in cancer treatment
September 7, 2023/Cancer/News & Insight
Eye Toxicities More Prevalent Side Effect of Cancer Treatment Than Previously Understood

Early communication between oncologists and ophthalmologist warranted

23-CNR-4185077-CQD-Hero-650×450
August 31, 2023/Cancer/News & Insight
CME Program Takes Multidisciplinary Approach to Colorectal Cancer

Case-based course delves into latest treatment approaches

outreach to underserved communities
June 2, 2023/Cancer/News & Insight
Focus Groups Amplify the Voices of Black Congregants about Disparities in Clinical Trials

Long-term relationship building and engagement key to gaining community trust

Ad